# Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome

> **NCT00004500** · PHASE3 · TERMINATED · sponsor: **Windtree Therapeutics** · enrollment: 69 (actual)

## Conditions studied

- Meconium Aspiration

## Interventions

- **DRUG:** Lucinactant
- **OTHER:** Standard Care

## Key facts

- **NCT ID:** NCT00004500
- **Lead sponsor:** Windtree Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-03
- **Primary completion:** 2002-11
- **Final completion:** 2004-11
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** Slow enrollment and administrative reasons
- **Last updated:** 2012-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004500, "Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00004500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*